Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
NCT02119091
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Cardiac Toxicity
Interventions
DRUG:
Moxifloxacin
Sponsor
Haiyan Li
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]